Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: A randomized trial

Liver

Volumn 19, Issue 4, 1999, Pages 275-280

  Salmerón, Javier ^a   Ruiz Extremera, Angela ^a   Torres, Cristina ^a   Rodríguez Ramos, Luis ^a   Lavín, Isabel ^a   Quintero, Dolores ^a   Palacios, Angel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

HCV RNA; Hepatitis C therapy; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; HEMOGLOBIN; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FEVER; FREE LIOTHYRONINE INDEX; HEPATITIS C; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TACHYCARDIA;

ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; BIOPSY; DNA PRIMERS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0032794247     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00049.x     Document Type: Article

References (26)

1. DAVIS G, BALART L, SHIFF E, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-6.
2. REICHARD O, FOBERG U, FRYDÉN A, et al. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon alfa-2b for 60 weeks. Hepatology 1994; 19: 280-5.
3. POYNARD T, BEDOSSA P, CHEVALLIER M, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995; 332: 1457-62.
4. SIDWELL R W, HUFFMAN J H, KHARE G P, ALLEN L B, WITKOWSKI J T, ROBINS R K. Broad-spectrum antiviral activity of virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carbozamide. Science 1972; 177: 705-6.
5. REICHARD O, ADERSSON J, SCHVARCZ R, WEILAND O. Ribavirin treatment for chronic hepatitis C. Lancet 1991; 337: 1058-81.
6. DI BISCEGLIE A, SHINDO M, FONG T L, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16: 649-54.
7. KOSKINAS J, TIBBS C H, SALEH M G, PEREIRA L, MCFARLANE I G, WILLIAMS R. Effects of ribavirin on intra-hepatic and extrahepatic expression of hepatitis C virus in interferon nonresponsive patients. J Med Virol 1995; 45: 29-34.
8. DI BISCEGLIE A M, CONJEEVARAM H S, FRIED M W, et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995; 123: 897-903.
9. CHEMELLO L, CAVALLETTO L, BERNARDINELLO E, GUIDO M, PONTISSO P, ALBERTI A. The effects of interferon alfa and ribavirin combination therapy in native patients with chronic hepatitis C. J Hepatol 1995; 23 (Suppl 2): 8-12.
10. BRILLANTI S, GARSON J, FOLI M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994; 107: 812-7.
11. KAKUMU S, YOSHIOKA K, WAKITA T, ISHIIKAWA T, TAKAYANAGI M, HIGASHI Y. A pilot study of ribavirin and interferon beta for treatment of chronic hepatitis C. Gastroenterology 1993; 105: 507-12.
12. SCHVARCZ R, ANDO Y, SÖNNERBORG A, WEILAND O. Combination treatment with interferon alfa-2a and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience. J Hepatol 1995; 23 (Suppl 2): 17-21.
13. BRILLANTI S, MIGLIOLI M, BARBARA L. Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience. J Hepatol 1995; 23 (Suppl 2): 13-6.
14. DAVIS G L, ESTEBAN-MUR R, RUSTGI V, et al. Retreatment of relapse after interferon therapy for chronic hepatitis C: an international randomized controlled trial of interferon plus ribavirin vs interferon alone. Hepatology 1997; 26: 247A.
15. REICHARD O, NORKRANS G, FRYDÉN A, BRACONIER J H, SÖNNERBORG A, WEILAND O. Randomised, double-blind, placebo-controlled trial of interferon alfa-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83-7.
16. BIANCHI L, DE GROOTE J, DESMET J, et al. Acute and chronic hepatitis revisited. Review by an International Group. Lancet 1977; 2: 914-9.
17. KNODELL R G, ISHAK K G, BLACK W C, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
18. CHOMCZYNSKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
19. GARSON JA, TEDDER RS, BRIGGS M, et al. Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-22.
20. ROMEO R, POL S, BERTHELOT P, BRECHOT CH. Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med 1994; 121: 276-7.
21. QIAN C, CAMPS J, MALUENDA MD, CIVEIRA MP, PRIETO J. Replication of hepatitis C virus in peripheral blood mononuclear cells. J Hepatol 1992; 16: 380-3.
22. GIL B, QIAN C, RIEZU-BOJ JI, CIVEIRA MP, PRIETO J. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Hepatology 1993; 18: 1050-4.
23. YUN Z-B, SÖNNERBORG A, WEILAND O. Hepatitis C virus replication in liver and peripheral blood mononuclear cells of interferon-alpha-treated and untreated patients with chronic hepatitis C. Scand J Gastroenterol 1994; 29: 82-6.
24. SARACCO G, ROSINA F, ABATE M L, et al. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon alfa-2b. Hepatology 1993; 18: 1300-5.
25. NOUSBAUM J B, POL S, NALPAS B, LANDAIS P, BERTHELOT P, BERCHOT C AND THE COLLABORATIVE STUDY GROUP. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-8
26. POL S, BERTHELOT P, BRECHOT C AND A MULTICENTER FRENCH STUDY GROUP. Ribavirin plus interferon alfa-2b combination shows increased efficiency compared to high doses of alfa IFN alone in naive patients infected by genotype 1B. Hepatology 1998; 28: 507A.